Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Segmentation Artificial Intelligence (AI) For Pathology Slides Market Size Forecast: How Big Could The Market Get By 2030?
The market for segmentation artificial intelligence (AI) for pathology slides has experienced rapid expansion in recent years. It is projected to increase from $1.02 billion in 2025 to $1.27 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 24.2%. Historically, this expansion has been driven by factors such as the surging demand for precise tissue analysis, the rising acceptance of digital pathology, the escalating need for high-throughput slide examination, the broader application of AI-assisted diagnostics, and a heightened emphasis on minimizing human error in pathology processes.
The segmentation artificial intelligence (AI) for pathology slides market size is projected to experience substantial expansion over the upcoming years, reaching $2.98 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 23.9%. This anticipated growth during the forecast period stems from factors such as the increasing incorporation of deep learning into pathology workflows, the rising uptake of automated segmentation instruments, a growing need for real-time slide examination, augmented investment in AI-powered diagnostic solutions, and a heightened focus on precision medicine and tailored treatments. Key developments expected during this period involve technological progress in neural network-based segmentation, breakthroughs in AI-driven pattern recognition, enhancements in high-resolution digital slide processing, ongoing research and development in multi-modal pathology analysis, and advancements in cloud-based AI pathology platforms.
Get A Free Sample Report With In-Depth Market Insights:
Segmentation Artificial Intelligence (AI) For Pathology Slides Market Growth Momentum: What Factors Are Shaping Demand?
The increasing incidence of cancer is anticipated to drive the expansion of the segmentation artificial intelligence (AI) for pathology slides market moving forward. Cancer is a condition marked by the uncontrolled multiplication and spread of abnormal cells, which can harm adjacent tissues and organs if not effectively addressed. The occurrence of cancer is on the rise due to lifestyle factors such as inadequate diet, smoking, alcohol consumption, and exposure to environmental pollutants, all of which elevate the likelihood of developing various cancers. Segmentation artificial intelligence (AI) for pathology slides aids in managing cancer by automatically pinpointing and delineating tumor areas within digital tissue images. This technology improves diagnostic accuracy and efficiency, thereby enabling more precise treatment planning and tailored therapeutic approaches. For instance, in October 2025, according to NHS Digital, a UK government organisation, there were 354,820 new cancer diagnoses recorded in England in 2023, averaging 972 diagnoses per day and representing an increase of 8,605 cases compared to 2022, with prostate cancer being the most commonly diagnosed cancer at 58,137 new cases, reflecting a 6% increase in registrations compared to the previous year. Consequently, the growing prevalence of cancer is fueling the growth of the segmentation artificial intelligence (AI) for pathology slides market.
Segmentation Artificial Intelligence (AI) For Pathology Slides Market Segment Analysis: What Are The Core Market Categories?
The segmentation artificial intelligence (AI) for pathology slides market covered in this report is segmented –
1) By Component: Software, Hardware, Services
2) By Technology: Deep Learning-Based Segmentation, Convolutional Neural Network (CNN) Models, Multi-Class Tissue Classification, Hybrid AI Models (Rule-Based + ML)
3) By Deployment Mode: Cloud-Based AI Platforms, On-Premise AI Systems, Hybrid AI Deployment
4) By Application: Cancer Diagnosis, Disease Detection, Research, Drug Development, Other Applications
5) By End User: Hospitals, Diagnostic Laboratories, Research Institutes, Pharmaceutical And Biotechnology Companies, Others End Users
Subsegments:
1) By Software: Image Processing Algorithms, Deep Learning Models, Annotation Tools, Workflow Integration Platforms, Model Training Frameworks
2) By Hardware: High-Performance Computing Systems, Graphics Processing Units, Dedicated Inference Devices, Data Storage Servers, Edge Processing Units
3) By Services: Deployment Services, Integration Services, Training And Support Services, Validation And Testing Services, Maintenance And Upgradation Services
Segmentation Artificial Intelligence (AI) For Pathology Slides Market Trends Redefining Industry Growth
Companies operating in the segmentation AI for pathology slides market are concentrating on developing advanced tissue segmentation solutions, such as AI-driven whole slide image analysis platforms, to enhance diagnostic accuracy, minimize manual annotation, and speed up pathology workflows. AI-powered whole slide image analysis platforms are software systems that automatically identify and delineate tissue regions, cells, and anomalies within digital pathology slides, enabling pathologists to conduct accurate and reproducible assessments efficiently. For example, in June 2024, HistoWiz Inc., a US-based digital pathology services company, introduced PathologyMap 2.0. This integrated AI-powered whole slide image analysis platform performs automated tissue segmentation, offers one-click quality control of whole slide images, and supports flexible metadata integration across slide repositories. These functionalities facilitate rapid tissue identification, streamline slide review, and ensure consistent segmentation outputs for subsequent diagnostic and research applications. By integrating high-throughput AI segmentation, built-in quality checks, and workflow compatibility, PathologyMap 2.0 signifies a substantial advancement in digital pathology, improving both operational efficiency and diagnostic confidence.
Segmentation Artificial Intelligence (AI) For Pathology Slides Market Key Players Shaping Industry Direction
Major companies operating in the segmentation artificial intelligence (AI) for pathology slides market are PathAI Inc., Lunit Inc., Deciphex Ltd., AetherAI Co. Ltd., Proscia Inc., Aignostics GmbH, Visiopharm A/S, Indica Labs Inc., PathPresenter Ltd., Gestalt Diagnostics Inc., Ibex Medical Analytics Ltd., HistoWiz Inc., Deep Bio Inc., Mindpeak GmbH, Nucleai Ltd., Vuno Inc., Aiosyn B.V., Aiforia Technologies Oyj, Stratipath Medical Ltd., AIVIS Inc.
View The Full Segmentation Artificial Intelligence (AI) For Pathology Slides Market Report:
Segmentation Artificial Intelligence (AI) For Pathology Slides Market Regional Analysis: Which Geography Leads On Revenue?
North America was the largest region in the segmentation artificial intelligence (AI) for pathology slides market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the segmentation artificial intelligence (AI) for pathology slides market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
